Statistics

Total Visits

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period83

File Visits

Downloads
35543-24.pdf53

Select a period of time:

Number of views in the range

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period51

Number of downloads in the range

Downloads
35543-24.pdf16

Views

Views
October 20242
November 20241
December 20241
January 20252
February 20254
March 202518
April 202523
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • October 2024
    3
  • November 2024
    2
  • December 2024
    3
  • January 2025
    5
  • February 2025
    0
  • March 2025
    0
  • April 2025
    3
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States22
Singapore17
Hong Kong10
United Kingdom2
 

Top countries by downloads

Downloads
United States8
Hong Kong2
 

Top cities views

Views
The Dalles10
Hong Kong10
Council Bluffs1
 

Top cities by downloads

Downloads
Hong Kong2